"Narcotic Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents inhibiting the effect of narcotics on the central nervous system.
| Descriptor ID |
D009292
|
| MeSH Number(s) |
D27.505.696.543 D27.505.696.663.850.512 D27.505.954.427.550
|
| Concept/Terms |
Narcotic Antagonists- Narcotic Antagonists
- Antagonists, Narcotic
- Opioid Receptor Antagonists
- Antagonists, Opioid Receptor
- Receptor Antagonists, Opioid
- Opioid Antagonists
- Antagonists, Opioid
|
Below are MeSH descriptors whose meaning is more general than "Narcotic Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Narcotic Antagonists".
This graph shows the total number of publications written about "Narcotic Antagonists" by people in this website by year, and whether "Narcotic Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 1 | 3 |
| 1997 | 4 | 0 | 4 |
| 1998 | 1 | 0 | 1 |
| 1999 | 6 | 0 | 6 |
| 2000 | 5 | 1 | 6 |
| 2001 | 3 | 1 | 4 |
| 2002 | 5 | 3 | 8 |
| 2003 | 0 | 1 | 1 |
| 2004 | 4 | 1 | 5 |
| 2005 | 1 | 1 | 2 |
| 2006 | 6 | 1 | 7 |
| 2007 | 4 | 3 | 7 |
| 2008 | 5 | 1 | 6 |
| 2009 | 5 | 2 | 7 |
| 2010 | 3 | 1 | 4 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 2 | 3 |
| 2013 | 7 | 0 | 7 |
| 2014 | 6 | 1 | 7 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 2 | 4 |
| 2018 | 1 | 3 | 4 |
| 2019 | 5 | 4 | 9 |
| 2020 | 1 | 2 | 3 |
| 2021 | 1 | 2 | 3 |
| 2022 | 0 | 2 | 2 |
| 2024 | 5 | 2 | 7 |
| 2025 | 1 | 5 | 6 |
| 2026 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Narcotic Antagonists" by people in Profiles.
-
Correlates of Rural Naloxone Possession Among People Who Use Drugs: A Multi-State Cross-Sectional Analysis. J Rural Health. 2026 Jun; 42(3):e70187.
-
Evaluation of an Opioid Use Disorder Consult Service on Success of Non-Home Discharge Recommendations. Subst Use Addctn J. 2026 Jul; 47(3):834-841.
-
Public Support for Harm Reduction Strategies to Address the Opioid Pandemic in the United States: A Latent Class Analysis. Subst Use Misuse. 2026; 61(10):1719-1727.
-
Initiation, retention, and discontinuation of extended-release buprenorphine (BUP-XR) for opioid dependence: A single-arm multi-site trial in Ukraine. Int J Drug Policy. 2026 02; 148:105107.
-
Implementing incentives in family medicine for opioid use disorder treatment: a qualitative inquiry on provider and patient preferences for a low magnitude reward program compatible with buprenorphine treatment. Addict Sci Clin Pract. 2025 12 22; 20(1):97.
-
Barriers to Universal Availability of Medications for Opioid Use Disorder in US Jails. JAMA Netw Open. 2025 04 01; 8(4):e255340.
-
Comparing efficacy of serotonergic, opioidergic, and glutamatergic drugs in gambling disorder: A pooled analysis of response trajectories versus placebo. J Psychiatr Res. 2025 05; 185:112-118.
-
Differences by race and ethnicity in drug use patterns, harm reduction practices and barriers to treatment among people who use drugs in Rhode Island. Harm Reduct J. 2025 03 20; 22(1):38.
-
Trait Impulsivity Predicts Treatment Response in Gambling Disorder. Clin Neuropharmacol. 2025 Mar-Apr 01; 48(2):27-28.
-
The CARE Overdose Response Team in Chicago: A Multidisciplinary Out-of-Hospital Post-Opioid Overdose Intervention. Prehosp Emerg Care. 2025; 29(4):534-539.